Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol: A Randomized Controlled Trial

Study Questions:

What are the biochemical effects, safety, and tolerability of evacetrapib, a cholesteryl ester transfer protein inhibitor (CETPi), as monotherapy and in combination with statins, in patients with dyslipidemia?